Wereport a case of an anti-nuclear antibody (ANA)-negative patient with systemic lupus erythematosus (SLE) accompanied with anti-phospholipid antibody syndrome (APS) and lupus nephritis (LN). Histological examination of placenta obtained by an artificially-induced abortion revealed multiple thromboses in the placental villi. Histology of biopsied kidney tissue revealed minimal change with deposits of immunoglobulinand complement. Anti-ribosomal P antibodies (anti-P) and lupus anticoagulant (LAC) were positive and anti-double stranded DNAantibody (anti-DNA)showed only a slightly positive titer in her serum. The intensity of proteinuria of the patient was correlated with the anti-P, but not anti-DNA titers.
Introduction
Systemic lupus erythematosus (SLE) is a prototype autoimmunedisease. Various kinds of autoantibodies such as antinuclear antibodies (ANA), anti-cytoplasmic antibodies and antiplasma membraneantibodies are present in sera of SLEpatients (1) . ANAis a diagnostic hallmark for SLE, having a frequency of 95% or greater in patients with SLE (2) . ANA-negative patients with SLEhave also been reported (3) . ANA-negative SLEpatients have been known to have a higher prevalence of both anti-Ro antibody, one of the anti-cytoplasmic antibodies, and cutaneous manifestation, as well as a lower prevalence of both central nervous system (CNS)and renal involvement than ANA-positive SLE patients (4, 5) . In addition to anti-phospholipid antibodies (aPL), one of the anti-plasma membrane antibodies, and other autoantibodies are often detected in patients with ANA-negative SLE (4) . Anti-phospholipid antibodies cause anti-phospholipid antibody syndrome (APS), which is characterized by the presence of thromboembolic symptoms (6, 7) . Recurrent fetal loss due to thrombosis of the placenta is one of the most prominent symptoms ofAPS (8) . Anti-ribosomal P antibodies (anti-P), one of the anti-cytoplasmic antibodies, have also been found in patients, with a prevalence of 5 to 42% (9) (10) (11) (12) (13) (14) . Anti-P is believed to be associated with neuropsychiatric disorders (12, 15, 16) , as well as liver and kidney lesions in patients with SLE (17, 18). Here, we report a case of an ANA-negative, but lupus anticoagulant (LAC) and anti-P-positive, SLE patient who presented with a thrombosis in the placental villi of placenta taken from an artificially-induced abortion, and immune deposits in biopsied kidney tissue. The clinical significance of LACand anti-P in ANA-negative SLE patients is discussed.
Case Report
A 28-year-old womanhas been suffering from low grade fever, facial erythema, cervical lymphadenopathy, epigastric discomfort, polyarthritis and headache since February 2001. The patient visited Ohta Nishinouchi Hospital, in Koriyama, Japan, on April 12, 2001 . Laboratory data of the patient were as follows: white blood cells (WBC); 3,100/mm3 (normal, 3,500-9,000), complement; 1 1.9 IU/ml (normal, 30-50), lower positive titer of anti-dsDNA antibody; 8 IU/ml (normal, less than 6), positive lupus anticoagulant, and proteinuria; 30 mg/ swollen cervical lymphnodes and polyarthritis in both elbows, wrists and knees were noted. , low positive titer of anti-dsDNA antibody at 9 IU/ml (normal, less than 6), low positive titer of anti-cardiolipin IgG antibody at 14.0 GPL (normal, less than 10) and high positive titer of anti-P at 250 index (normal, less than 10) tested using a commercial ELISAkit. However, serum ANAin an indirect immunofluorescence test using Hep2 cell substrates was negative in three repeated tests. Noneof anti-RNP, anti-Sm, anti-Ro, anti-La, anti-Scl-70 or anti-p2GPI antibody was detected using routine commercial ELISAkits. Urinalysis revealed proteinuria at 225 mg/dl. RBC(at 10 to 20 cells in one field at x40 magnification), numerous WBCand bacteria were observed in sediment without urinary cast. Her HLAloci were A24, A26, B35, B60, CW3, DR14 and DQ1. Persistent fever of 37.5-38.5°C and exacerbation of facial erythema, lymphadenopathy, polyarthritis, proteinuria and hypocomplementemia prompted an increase in the prednisolone dose to 40 mg/day. Subsequently, facial erythema, cervical lymphadenopathy, polyarthritis as well as the fever were ameliorated. However, proteinuria of 2.0 g/day or greater and hypocomplementemia of less than 20 IU/ml continued. To avoid a poor prognosis, an artificially-induced abortion was performed on June 6th, 2001, at the llth week of gestation under permission of both the patient and her husband. One week after the induced abortion, her proteinuria levels decreased. Moreover both anti-P and LACtiters diminished one month after the induced abortion (Fig. 1) . Histological examination of the placenta obtained at the time of the induced abortion revealed multiple micro-thrombosisin the small vessels in the placental villi (Fig. 2) . Pathohistology of renal biopsy tissue obtained on July 7, 2001 , revealed a mild mesangial proliferation ( Fig. 3A) lins and complementcomponentsin the mesangial area and capillary walls of the glomerulus ( Fig. 3B and C) . These findings were compatible with the WHO classification of LNIb.
Discussion
Patients with ANA-negative SLE have been reported to have a higher prevalence of skin rashes and mucousmembranous ulcers and a lower prevalence of renal and central nervous system involvement than ANA-positive patients (4, 5) . Furthermore, Meyer et al reported that the prevalence of arterial and venous thrombosis with thrombocytopenia in ANA-negative patients with SLEwas higher than ANA-positive patients, and also that anti-phospholipid antibody (aPL) and lupus anticoagulant (LAC) were commonin ANA-negative patients with SLE (6). Recently, anti-P, one of the anti-cytoplasmic, was specifically found in patients with SLE (19), particularly in those complicated by neuropsychiatric disorders (12, 15, 16 ) and liver and kidney lesions (17, 18). Moreover, Chindalore et al reported that the titer of anti-P was correlated with the activity of renal lesions in 13 patients with SLE (20). The patient presented in this report suffered from proteinuria with high positive titers of anti-P but low positive titers of anti-dsDNAantibody. Therefore, the anti-P in our patient maybe associated with the renal lesions.
The importance of female sex hormones in the production of autoantibodies and the occurrence of SLEhad been extensively discussed (2 1-24) . In the present patient, proteinuria was ameliorated after the artificially-induced abortion, in accordance with the decrease in the titers of both anti-P and LAC. These results suggest that the patient's pregnancy mayhave played components (Clq; 9.1 mg/dl, C3; 55.4 mg/dl, C4; 3.3 mg/dl, C5; 13.3 mg/dl, C6; 5.1 mg/dl, C7; 6.0 mg/dl, C8; 5.7 mg/dl, and C9; 7.1 mg/dl) (25) .
Studies have shown that immune complex (IC) composed of anti-dsDNA antibody activates the complement cascade, whereas anti-phospholipid antibody does not (26, 27) . Recently, however, Munakataet al reported that someanti-phospholipid antibody ICs activate the complement cascade (28) . In the present patient, hypocomplementemia was observed along with higher positive titers of LACand anti-P but lower positive titers of anti-DNA. In addition, a prominent deposition of immunoglobulinsand complement componentswere observed in the glomerulus of the biopsied kidney tissue. Therefore, it is plausible that LACand/or anti-P antibody, clustered with IgG anticardiolipin in the patient, could activate complement cascade and cause internal organ damage such as LN. Recently, Ghirardello et al reported that anti-P is strongly clustered with IgG anticardiolipin antibodies in lupus sera, even if they are independently elucidated (19). In the present patient, anti-P may have clustered with LAC, and these two autoantibodies may have participated together to bring about renal lesions unrelated to the anti-DNA titers. Furthermore, pathogenetic potentials of anti-P in LN have been reported (29, 30) . Recently it has been reported that anti-p2GPI antibody as well as LACis closely related with thromboembolic events in patient with APS (3 1, 32 ). Positive LAC without anti-(32GPI antibody were observed in this patient. In our case it maybe possible to speculate LAC,not anti-(32GPI antibody, causes micro-thrombosis in the small vessels in the placental villi. ANA-negative SLE is considered to be as heterogeneous as ANA-positive SLE. Previous reports have indicated the existence of two major subpopulations in ANA-negative SLE patients. The first manifests cutaneous involvement with anti-Ro antibody, which is one of the anti-cytoplasmic antibodies, and the second exhibits secondary APSwith aPL, which is one of the anti-plasma membraneantibodies. In general, in these two major two subpopulations ofANA-negative SLE, renal involvement as well as CNSinvolvement is less commonthan in ANApositive SLE cases. The present patient may indicate the existence of a third subpopulation of ANA-negative SLE; one exhibits renal lesions with anti-P. Wehave treated two other ANAnegative SLE patients of 120 SLE patients belonging to our Division of Rheumatology (unpublished data). One patient suffered from LNand the other suffered from CNSlupus, while both had high titers of anti-P in their active phase of the disease. Detailed evaluation of anti-P will provide more precise clinical information for patients with ANA-negative SLE. In conclusion, we report an ANA-negativeSLEpatient accompanied with APS and LN, in whomhigh positive titers of both anti-P and LACwere observed. The serum level of anti-P, but not anti-DNA, was correlated with the disease activity and the amount of proteinuria. The measurement of anti-P is useful for characterization of the clinical features of SLEand to predict the outcome of SLE patients, in particular ANA-negative SLE patients. 19) Ghirardello A, DoriaA, Zampieri S, Gerli R, Rapizzi E, Gambari PF. Anti-ribosomal P protein antibodies detected by immunoblotting in pa- 
